Anticancer Therapies – Multimedia

Download this listicle to discover new biological insights, explore various drug modalities and uncover novel drug combinations.

Discovery of novel immunotherapies that specifically target and enhance the T cell response against cancer is a rapidly expanding research area. Robust and relevant in vitro models for evaluation of these immunotherapies is essential throughout their development.

Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat an array of genetic diseases. All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell.

Download this infographic to explore major cancer drug discovery milestones throughout history and the five pillars of modern-day cancer treatment.

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy, and combination immunotherapies increase cost of treatment and heighten the risk for toxicity-related adverse events.

Four researchers share their thoughts on how mRNA vaccine technology will transform cancer treatment in the future.

One of the more promising types of cancer immunotherapy involves engineering immune cells to recognize and attack cancer.

Delivering drugs directly to cancer cells could help reduce the unpleasant side effects of chemotherapy.

The successful use of immunotherapies to help combat cancer has expanded rapidly in the last few years, with many therapies now approved for clinical use.